EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Prolonged Consumption of A2 β-Casein Milk Reduces Symptoms Compared to A1 and A2 β-Casein Milk in Lactose Maldigesters: A Two-Week Adaptation Study

Monica Ramakrishnan, Sindusha Mysore Saiprasad, Dennis A Savaiano iD

Nutrients · 2024

DOI: 10.3390/nu16121963 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Monica Ramakrishnan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition Science, College of Health and Human Sciences, Purdue University, West Lafayette, IN 47907, USA. Hauptthemen laut MEDLINE: Lactose Intolerance, Caseins, Milk, Cross-Over Studies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, The a2 milk company ltd, The a2 Milk Company Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Approximately 30% of milk protein is β-casein. We aimed to determine whether lactose maldigesters who chronically consumed two cups of A1/A2 milk (containing 75% A1 β-casein and 25% A2 β-casein) would adapt to have fewer intolerance symptoms, lower serum inflammatory markers, and/or altered glutathione levels similar to those consuming A2 milk (containing 100% A2 β-casein). A double-blinded, randomized, crossover trial was conducted. Sixteen confirmed lactose maldigesters consumed 250 mL of A1/A2 milk and A2 milk twice daily with meals for two weeks. At the end of the adaptation period on day 15, lactose maldigestion was measured after a challenge with the same milk used for adaptation (0.5 g of lactose per kg of body weight) with a hydrogen breath test. Fecal urgency was higher during the two-week consumption of A1/A2 milk compared to A2 milk (p = 0.04, n = 16). Bloating (p = 0.03, n = 16) and flatulence (p = 0.02, n = 16) were also higher on the 15th day with A1/A2 milk compared to A2 milk challenge. However, day-to-day symptoms, hydrogen, serum inflammatory markers, and antioxidant concentrations were not different after A1/A2 and A2 milk consumption adaptation periods. Adaptation over two weeks did not improve lactose digestion or tolerance of A1/A2 milk to match that of A2 milk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lactose IntoleranceCaseinsMilkCross-Over StudiesHumansFemaleDouble-Blind MethodAdultAnimalsMaleLactoseMiddle AgedBiomarkersFlatulenceBreath TestsAdaptation, Physiological

Stichwörter der Autor:innen

A1 β-caseinA2 milkA2 β-caseinbetacasomorphin-7inflammationlactose intolerancelactose maldigestion

Substanzen

CaseinsLactoseBiomarkers

Autor:innen und Institutionen

  • Department of Nutrition Science, College of Health and Human Sciences, Purdue University, West Lafayette, IN 47907, USA.

ORCID-Profile: Dennis A Savaiano

Förderung

  • NIDDK NIH HHS
  • The a2 milk company ltd
  • The a2 Milk Company Ltd.

Zitieren

APA

Ramakrishnan, M., Mysore Saiprasad, S., & Savaiano, D. A. (2024). Prolonged Consumption of A2 β-Casein Milk Reduces Symptoms Compared to A1 and A2 β-Casein Milk in Lactose Maldigesters: A Two-Week Adaptation Study. Nutrients. https://doi.org/10.3390/nu16121963

Vancouver

Ramakrishnan M, Mysore Saiprasad S, Savaiano DA. Prolonged Consumption of A2 β-Casein Milk Reduces Symptoms Compared to A1 and A2 β-Casein Milk in Lactose Maldigesters: A Two-Week Adaptation Study. Nutrients. 2024. doi:10.3390/nu16121963

BibTeX
@article{Ramakrishnan2024,
  author = {Ramakrishnan, Monica and Mysore Saiprasad, Sindusha and Savaiano, Dennis A},
  title = {Prolonged Consumption of A2 β-Casein Milk Reduces Symptoms Compared to A1 and A2 β-Casein Milk in Lactose Maldigesters: A Two-Week Adaptation Study},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16121963}
}
Kostenlos starten →